SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001570562-24-000003
Filing Date
2024-01-16
Accepted
2024-01-16 17:28:48
Documents
14
Period of Report
2024-01-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eols-20240116.htm   iXBRL 8-K 25595
2 EX-99.1 ex991012024.htm EX-99.1 35971
6 imagea.jpg GRAPHIC 10269
  Complete submission text file 0001570562-24-000003.txt   209186

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20240116.xsd EX-101.SCH 1911
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20240116_lab.xml EX-101.LAB 23834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20240116_pre.xml EX-101.PRE 12518
8 EXTRACTED XBRL INSTANCE DOCUMENT eols-20240116_htm.xml XML 2729
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38381 | Film No.: 24536166
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)